E.D. Wildschut

Dr. E.D. Wildschut is a Researcher at Erasmus MC's Neonatal and Pediatric Intensive Care department. Their work focuses on pediatric pharmacokinetics, critical care medicine, and ECMO management. Key areas include optimizing antibiotic therapies (e.g., vancomycin, ceftriaxone), anticoagulation strategies in ECMO patients, and pain management in infants undergoing cardiothoracic surgery.

Research interests span Pharmacokinetic Modeling, Hemostasis, and Clinical Outcomes in critical care settings. Recent studies include comparative trials of analgesics, ECMO anticoagulation protocols, and pediatric antibiotic efficacy evaluations.

Notable contributions include a landmark 2024 randomized controlled trial comparing paracetamol and morphine for post-surgical pain, and 2025 cohort studies addressing ECMO-related hemostatic challenges. Their work emphasizes translational research bridging clinical data and pharmacological models.